{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:42:54Z","timestamp":1793058174964,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 027"],"award-info":[{"award-number":["SRC 027"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eprac.2026.02.018","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:20:47Z","timestamp":1774311647000},"page":"1132-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High Incidence of Gestational Diabetes Mellitus in Females With Cystic Fibrosis Persists in the Triple Cystic Fibrosis Transmembrane Conductance Regulator Modulator Era: Implications for Screening"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0726-9508","authenticated-orcid":false,"given":"Amy","family":"Downes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladina","family":"Weitnauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Diable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.02.018_bib1","series-title":"UK Cystic Fibrosis Registry 2024 Annual Data Report","year":"2025"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"18","key":"10.1016\/j.eprac.2026.02.018_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2026.02.018_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.02.018_bib7","series-title":"2023 Annual Data Report","year":"2024"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/jcm12041468","article-title":"Pregnancy in cystic fibrosis-past, present, and future","volume":"12","author":"Gur","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.018_bib9","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.chest.2021.07.024","article-title":"Fertility and pregnancy in cystic fibrosis","volume":"160","author":"Shteinberg","year":"2021","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9378(70)90254-1","article-title":"Cervical mucus in cystic fibrosis: a possible cause of infertility","volume":"108","author":"Oppenheimer","year":"1970","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10995-016-2181-z","article-title":"Attitudes and decision making related to pregnancy among young women with cystic fibrosis","volume":"21","author":"Kazmerski","year":"2017","journal-title":"Matern Child Health J"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.018_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-0528.2000.tb11697.x","article-title":"The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977-1996","volume":"107","author":"Edenborough","year":"2000","journal-title":"BJOG"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2026.02.018_bib15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.02.018_bib16","article-title":"Gestational and pregestational diabetes in pregnant women with cystic fibrosis","volume":"27","author":"Oxman","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"S48","key":"10.1016\/j.eprac.2026.02.018_bib17","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/ppul.23762","article-title":"CF-related diabetes: containing the metabolic miscreant of cystic fibrosis","volume":"52","author":"Moheet","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.eprac.2026.02.018_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1515\/jpem-2019-0484","article-title":"Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment","volume":"33","author":"Alves","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2026.02.018_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis-related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1\u03b2 immunoreactivity is an early feature of cystic fibrosis that may contribute to \u03b2-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.018_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107845","article-title":"Effect of CFTR modulator therapy on cystic fibrosis-related diabetes","volume":"35","author":"Gaines","year":"2021","journal-title":"J Diabetes Complications"},{"issue":"11","key":"10.1016\/j.eprac.2026.02.018_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102899","article-title":"Advances in cystic fibrosis-related diabetes: current status and future directions","volume":"17","author":"Lurquin","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0740","article-title":"Association of body mass index with clinical outcomes in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"5","author":"Nagy","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eprac.2026.02.018_bib25","article-title":"Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes","volume":"33","author":"Lurquin","year":"2023","journal-title":"J Clin Transl Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2026.02.018_bib26","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0135","article-title":"Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review","volume":"14","author":"Lurquin","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/j.eprac.2026.02.018_bib27","series-title":"National gestational diabetes mellitus audit 2024-2025","year":"2025"},{"key":"10.1016\/j.eprac.2026.02.018_bib28","article-title":"Diabetes in pregnancy: management from preconception to the postnatal period","year":"2020","journal-title":"NICE guideline NG3"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.018_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17446651.2018.1476135","article-title":"Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review","volume":"14","author":"Farahvar","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.018_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/1471-0528.70075","article-title":"Obstetric and neonatal outcomes in pregnancies from a dedicated cystic fibrosis-maternal health service: a retrospective study","volume":"133","author":"Scott","year":"2026","journal-title":"BJOG"},{"key":"10.1016\/j.eprac.2026.02.018_bib31","series-title":"Management of Cystic Fibrosis Diabetes","year":"2022"},{"issue":"12","key":"10.1016\/j.eprac.2026.02.018_bib32","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/14767050903550659","article-title":"The fetal and maternal consequences of gestational diabetes mellitus","volume":"23","author":"Reece","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.02.018_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/aogs.13185","article-title":"Pregnancy outcome in women with cystic fibrosis-related diabetes","volume":"96","author":"Reynaud","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.eprac.2026.02.018_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108625","article-title":"The absolute and relative risk of type 2 diabetes after gestational diabetes: a systematic review and meta-analysis of 129 studies","volume":"171","author":"Dennison","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.eprac.2026.02.018_bib36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.018_bib37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41591-024-03356-1","article-title":"Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial","volume":"31","author":"Kusinski","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.eprac.2026.02.018_bib38","series-title":"UK Cystic Fibrosis Registry 2021 Annual Data Report","year":"2022"},{"issue":"8","key":"10.1016\/j.eprac.2026.02.018_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2025.103295","article-title":"The prevalence and risk factors of gestational diabetes mellitus recurrence: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2025","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.eprac.2026.02.018_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112949","article-title":"Gestational diabetes mellitus recurrence rate and risk factors: a systematic review and meta-analysis","volume":"230","author":"Pan","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); Planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.018_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","article-title":"Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation","volume":"20","author":"Taylor-Cousar","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.eprac.2026.02.018_bib43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/oxfordjournals.aje.a116408","article-title":"Race\/ethnicity and other risk factors for gestational diabetes","volume":"135","author":"Berkowitz","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eprac.2026.02.018_bib44","series-title":"Maternity services monthly statistics, final July 2025, provisional August 2025, official statistics","year":"2025"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.018_bib45","article-title":"Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design","volume":"9","author":"Jain","year":"2022","journal-title":"BMJ Open Respir Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:49:04Z","timestamp":1782467344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26008256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1530891X26008256"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.02.018","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Incidence of Gestational Diabetes Mellitus in Females With Cystic Fibrosis Persists in the Triple Cystic Fibrosis Transmembrane Conductance Regulator Modulator Era: Implications for Screening","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}